Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study

被引：0
|
作者：
Nagai, T. [1 ]
Nakanishi, N. [1 ]
Yamashita, Y. [2 ]
Muraoka, N. [3 ]
Umetsu, M. [4 ]
Nishimoto, Y. [5 ]
Takada, T. [6 ]
Ogihara, Y. [7 ]
Nishikawa, T. [7 ]
Ikeda, N. [8 ]
Otsui, K. [9 ]
Sueta, D. [10 ]
Tsubata, Y. [11 ]
Shoji, M. [12 ]
Matoba, S. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Kyoto, Japan
[2] Kyoto Univ, Cardiovasc Med, Kyoto, Japan
[3] Shizuoka Canc Ctr, Cardiol, Shizuoka, Japan
[4] Tohoku Univ Hosp, Vasc Surg, Sendai, Miyagi, Japan
[5] Osaka Gen Med Ctr, Cardiol, Osaka, Japan
[6] Tokyo Womens Med Univ, Cardiol, Tokyo, Japan
[7] Mie Univ, Cardiol & Nephrol, Grad Sch Med, Tsu, Mie, Japan
[8] Toho Univ, Cardiovasc Med, Ohashi Med Ctr, Tokyo, Japan
[9] Kobe Univ, Internal Med, Kobe, Hyogo, Japan
[10] Kumamoto Univ, Cardiovasc Med, Kumamoto, Japan
[11] Shimane Univ, Fac Med, Internal Med, Div Med Oncol & Resp Med, Izumo, Shimane, Japan
[12] Natl Canc Ctr, Cardiovasc Med, Tokyo, Japan
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study
    Wells, Alvin F.
    Jia, Bochao
    Xie, Li
    Valenzuela, Guillermo J.
    Keystone, Edward C.
    Li, Zhanguo
    Quebe, Amanda K.
    Griffing, Kirstin
    Otawa, Susan
    Haraoui, Boulos
    RHEUMATOLOGY AND THERAPY, 2021, 8 (02) : 987 - 1001
  • [42] Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study
    Alvin F. Wells
    Bochao Jia
    Li Xie
    Guillermo J. Valenzuela
    Edward C. Keystone
    Zhanguo Li
    Amanda K. Quebe
    Kirstin Griffing
    Susan Otawa
    Boulos Haraoui
    Rheumatology and Therapy, 2021, 8 : 987 - 1001
  • [43] Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis
    Yamanaka, Hisashi
    Tanaka, Yoshiya
    Hibino, Toshihiko
    Unmesh, Gopalakrishnan
    Shah, Chirag
    Bakhle, Dhananjay
    Stefanidis, Dimitris
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 108 - 115
  • [44] Selinexor maintenance for patients with TP53WT advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Scambia, Giovanni
    Vergote, Ignace
    Hamilton, Erika
    Fidalgo, Jose Perez
    Van Gorp, Toon
    Sehouli, Jalid
    Klat, Jaroslav
    Levy, Tally
    Welch, Stephen
    Richardson, Debra
    Alia, Eva Guerra
    Henry, Stephanie
    Wimberger, Pauline
    Miller, David
    Martinez, Jeronimo
    Monk, Bradley
    Kalyanapu, Pratheek
    Mirza, Mansoor Raza
    Makker, Vicky
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A5 - A5
  • [45] Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Sehouli, Jalid
    Vergote, Ignace
    Hamilton, Erika
    Fidalgo, Alejandro Perez
    Gorp, Toon Van
    Scambia, Giovanni
    Klat, Jaroslav
    Levy, Tally
    Welch, Stephen
    Richardson, Debra L.
    Alia, Eva Maria Guerra
    Henry, Stephanie
    Wimberger, Pauline
    Miller, David S.
    Martinez, Jeronimo
    Monk, Bradley J.
    Kalyanapu, Pratheek
    Mirza, Monsoor Raza
    Makker, Vicky
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A12 - A15
  • [46] Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3-month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long-term Use study
    Tobe, Kazuyuki
    Maegawa, Hiroshi
    Tabuchi, Hiromi
    Nakamura, Ichiro
    Uno, Satoshi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (05) : 1262 - 1271
  • [47] Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naive versus non-naive Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)
    Maegawa, Hiroshi
    Tobe, Kazuyuki
    Nakamura, Ichiro
    Uno, Satoshi
    DIABETOLOGY INTERNATIONAL, 2021, 12 (04) : 430 - 444
  • [48] Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM)
    Hiroshi Maegawa
    Kazuyuki Tobe
    Ichiro Nakamura
    Satoshi Uno
    Diabetology International, 2021, 12 : 430 - 444
  • [49] Long-term follow-up of ef fi cacy and safety of selinexor maintenance treatment in patients with TP53 wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Makker, Vicky
    Perez-Fidalgo, Jose Alejandro
    Valabrega, Giorgio
    Hamilton, Erika
    Van Gorp, Toon
    Sehouli, Jalid
    Reginacova, Klaudia
    Richardson, Debra L.
    Perri, Tamar
    Oza, Amit M.
    Miller, David S.
    Alia, Eva Maria Guerra
    De Giorgi, Ugo
    Henry, Stephanie
    Spitz, Daniel L.
    Wimberger, Pauline
    Bednarikova, Marketa
    Chon, Hye Sook
    Martinez-Garcia, Jeronimo
    Pisano, Carmela
    Berek, Jonathan S.
    Romero, Ignacio
    Scambia, Giovanni
    Farinas-Madrid, Lorena
    Buscema, Joseph
    Schochter, Fabienne
    Li, Kai
    Kalyanapu, Pratheek
    Walker, Christopher J.
    Vergote, Ignace
    GYNECOLOGIC ONCOLOGY, 2024, 185 : 202 - 211
  • [50] LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Gladman, D. D.
    Starr, M.
    Ranza, R.
    Bravo Perdomo, A. M.
    Strauss, M.
    Shawi, M.
    Han, C.
    Rampakakis, E.
    Ostor, A. Andrew
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1765
12345